Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Irinotecan × Clear all

Phase

Phase 2 139 Phase 3 33 Phase 1/2 27 Phase 1 16 Phase NA 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

enzalutamide 8 Saline Solution 8 Docetaxel 8 nilotinib 7 Fentanyl 7 Everolimus 7 Cyclophosphamide 7 Bupivacaine 7 Paclitaxel 6 Carboplatin 6 Bevacizumab 6 Sodium Chloride 5 Lidocaine 5 Letrozole 5 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5 Dexamethasone 5 Capecitabine 5 fludarabine 4 Trastuzumab 4 Tranexamic Acid 4 Tobacco Use Cessation Devices 4 Surveys and Questionnaires 4 Rituximab 4 Oxycodone 4 Nivolumab 4 Morphine 4 Leuprolide 4 Ipilimumab 4 Gefitinib 4 Aprepitant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01588990 2019-01-22

ASCENT

Hoffmann-La Roche

Phase 4 Completed

128 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡